65293-004-03 : NDC 2026 Code

65293-004-03 : Oritavancin ( Orbactiv )

Additionally :

You can get information about “65293-004-03” NDC code in 65293-004-03 in HTML format

HTML | 65293-004-03 in TXT (Plain Text) format

TXT | 65293-004-03 in PDF (Portable Document Format)

PDF | 65293-004-03 in XML format

XML formats.

NDC Code : 65293-004-03 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "65293-004-03",
    "PackageDescription": "3 VIAL, GLASS in 1 CARTON (65293-004-03)  &gt; 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (65293-004-01)",
    "NDC11Code": "65293-0004-03",
    "ProductNDC": "65293-004",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Orbactiv",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Oritavancin",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20140901",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA206334",
    "LabelerName": "The Medicines Company",
    "SubstanceName": "ORITAVANCIN",
    "StrengthNumber": "400",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": null,
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2014-09-12",
    "PackageNdcExcludeFlag": null,
    "ProductNdcExcludeFlag": null,
    "ListingRecordCertifiedThrough": null,
    "StartMarketingDatePackage": null,
    "EndMarketingDatePackage": null,
    "SamplePackage": null
  }
}